Navigation Links
Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories

tended to enter the dark compartment. Upon doing so, however, they were each given a mild foot-shock – an emotional experience that, by itself, was not strong enough to become a long-lasting memory. Some of the rats then had their amygdala chemically stimulated in order to determine what role it played in forming a memory of the experience.

When they placed the rats that received both the mild foot-shock and the amygdala stimulation back in the well-lit compartment, the researchers found the rats tended to remain there, demonstrating a memory for the foot shock they had received in the dark compartment. These rats, the researchers found, also showed an increase in the amount of the Arc protein in the hippocampus. On the other hand, rats that received only the mild foot-shock and no amygdala stimulation showed no increase in Arc protein. When placed in the well-lit compartment, they tended to enter the dark compartment, suggesting they didn't remember the foot shock.

"In a separate experiment, we chemically inactivated the amygdala in rats very soon after they received a strong foot-shock," McIntyre said. "We found the increase in Arc was reduced and these rats showed poor memory for the foot shock despite its high intensity.

This also shows that the amygdala is involved in forming a long-term memory."

The brain is extremely dynamic, McIntyre explained, with some genes in the brain, called "immediate early genes," changing after every experience. "We know the level of the immediate early gene that makes the Arc protein increases in the brain, simply in response to an exposure to a new environment," she said. "Our findings show that this gene makes more Arc protein in the hippocampus only if the experience is emotionally arousing or important enough to activate the amygdala and to be remembered days later."

The researchers were surprised to find no change in the gene that produced the Arc protein when th
'"/>




Page: 1 2 3

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
Other Medicine News:Health News:JAMA study shows what works in treating HIV-infected African children 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 3Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 4Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 5Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 6Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 7Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 8Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 9Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 10Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 11Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 12Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 13Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 14Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 15Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 16Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 2Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 3Health News:New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs 2Health News:New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs 3
Other Medicine Technology:Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10